Gene: HAPLN3
Official Full Name: hyaluronan and proteoglycan link protein 3provided by HGNC
Gene Summary: This gene belongs to the hyaluronan and proteoglycan binding link protein gene family. The protein encoded by this gene may function in hyaluronic acid binding and cell adhesion. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02327 | HAPLN3 Knockout cell line (HeLa) | Human | HAPLN3 | 1:3~1:6 | Negative | Online Inquiry |
KO02328 | HAPLN3 Knockout cell line (HCT 116) | Human | HAPLN3 | 1:2~1:4 | Negative | Online Inquiry |
KO02329 | HAPLN3 Knockout cell line (HEK293) | Human | HAPLN3 | 1:3~1:6 | Negative | Online Inquiry |
KO02330 | HAPLN3 Knockout cell line (A549) | Human | HAPLN3 | 1:3~1:4 | Negative | Online Inquiry |
HAPLN3 Gene Knockout Cell Lines represent an advanced tool in genetic research, specifically designed to facilitate the study of the HAPLN3 gene's functional roles and associated pathways. By employing CRISPR-Cas9 technology, these cell lines enable precise knockout of the HAPLN3 gene, which is known to play a crucial role in the regulation of extracellular matrix composition and cellular signaling. The mechanism of action relies on the targeted disruption of the gene coding sequence, leading to a complete absence of the HAPLN3 protein, thus allowing researchers to analyze resultant phenotypic changes in cellular behavior and molecular processes.
The scientific importance of HAPLN3 Gene Knockout Cell Lines is underscored by the gene's involvement in various biological processes, including tissue development, repair, and disease pathology. These cell lines are invaluable in biomedical research, providing insight into the gene's role in conditions such as cancer, fibrosis, and other disorders linked to extracellular matrix dysfunction. Furthermore, when paired with assays for cellular proliferation, migration, and differentiation, researchers can elucidate the broader implications of HAPLN3 modulation in disease contexts.
Compared to alternative knockout models, our HAPLN3 Gene Knockout Cell Lines offer unparalleled specificity and reliability. They are developed in a controlled laboratory environment, ensuring high purity and consistent genetic modifications. This specificity reduces off-target effects often seen with other gene-editing methods, resulting in more accurate and reproducible experimental outcomes.
For researchers and clinicians, the value of utilizing HAPLN3 Gene Knockout Cell Lines lies in their potential to reveal novel therapeutic targets and pathways that could lead to the development of effective treatments. Moreover, by providing optimized cell lines that streamline experimentation, our product empowers users to accelerate their research timelines and enhance overall productivity.
Our company brings extensive experience in developing innovative biological products, backed by a commitment to quality and scientific rigor. By offering HAPLN3 Gene Knockout Cell Lines, we continue to support the research community with advanced tools that drive scientific discovery and pave the way for future breakthroughs in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.